Financial Freedom LLC’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$511 Hold
3
﹤0.01% 416
2025
Q4
$452 Hold
3
﹤0.01% 334
2025
Q3
$421 Hold
3
﹤0.01% 354
2025
Q2
$397 Hold
3
﹤0.01% 350
2025
Q1
$355 Hold
3
﹤0.01% 361
2024
Q4
$310 Hold
3
﹤0.01% 358
2024
Q3
$366 Hold
3
﹤0.01% 354
2024
Q2
$339 Hold
3
﹤0.01% 368
2024
Q1
$298 Hold
3
﹤0.01% 360
2023
Q4
$311 Hold
3
﹤0.01% 356
2023
Q3
$314 Hold
3
﹤0.01% 366
2023
Q2
$311 Hold
3
﹤0.01% 400
2023
Q1
$284 Hold
3
﹤0.01% 396
2022
Q4
$272 Buy
+3
New +$253 ﹤0.01% 400

Other funds holding NVS

Financial Freedom LLC's NVS Position: Q1 2026 in Review

Financial Freedom LLC held its Novartis (NVS) position steady in Q1 2026 at 3 shares worth $511. The position accounts for ﹤0.01% of the portfolio, ranked #416.

Financial Freedom LLC first reported a position in NVS in Q4 2022 and has held it in 14 quarters since. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Financial Freedom LLC held 3 shares of Novartis worth $511 as of Q1 2026.
  • Financial Freedom LLC left its Novartis share count unchanged in Q1 2026.
  • Novartis made up ﹤0.01% of Financial Freedom LLC's portfolio in Q1 2026, its #416 holding.
  • Financial Freedom LLC first reported a position in Novartis in Q4 2022 and has held it in 14 quarters since.
  • 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Financial Freedom LLC's 13F filing for Q1 2026, filed 30 Apr 2026.